The anti-osteosarcoma property of ailanthone through regulation of miR-126/VEGF-A axis.

Kong D, Ying B, Zhang J, Ying H

DOI: 10.1080/21691401.2019.1669622
Published: 2019 Dec
Container: Artificial cells, nanomedicine, and biotechnology
Publisher: Not recorded
Open access: no

Credibility signals

serious concern Score 16/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/21691401.2019.1669622,
  title = {The anti-osteosarcoma property of ailanthone through regulation of miR-126/VEGF-A axis.},
  author = {Kong D and Ying B and Zhang J and Ying H},
  year = {2019},
  journal = {Artificial cells, nanomedicine, and biotechnology},
  doi = {10.1080/21691401.2019.1669622},
  url = {https://doi.org/10.1080/21691401.2019.1669622}
}

RIS

TY  - JOUR
TI  - The anti-osteosarcoma property of ailanthone through regulation of miR-126/VEGF-A axis.
AU  - Kong D
AU  - Ying B
AU  - Zhang J
AU  - Ying H
PY  - 2019
JO  - Artificial cells, nanomedicine, and biotechnology
DO  - 10.1080/21691401.2019.1669622
UR  - https://doi.org/10.1080/21691401.2019.1669622
ER  -

APA

D, K., B, Y., J, Z., & H, Y. (2019). The anti-osteosarcoma property of ailanthone through regulation of miR-126/VEGF-A axis.. Artificial cells, nanomedicine, and biotechnology. https://doi.org/10.1080/21691401.2019.1669622

Source records

pubmed · retrieved 2026-09-25T12:00:23.446Z
europe-pmc · retrieved 2026-09-25T12:00:23.458Z
doaj · retrieved 2026-09-25T12:00:23.451Z